Published in AIDS Weekly, August 6th, 2007
Study 1: A new study, "Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort," is now available. "Since protease inhibitors (PIs) were first introduced in 1995, research has shown that use of PIs greatly improves rates of survival, while slowing HIV disease progression. However, there are concerns that use of PIs may be associated with an increased risk of cardiovascular disease (CVD)," researchers in the United States report.
"To examine the relationship between PI use and CVD among HIV-infected patients,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.